Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer
- PMID: 25888902
- PMCID: PMC4380100
- DOI: 10.1186/s12957-015-0510-0
Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer
Abstract
Background: The prognostic value of lymph node ratio (LNR) in pancreatic cancer remains controversial. In the current retrospective study, we assessed the value of LNR on predicting the survival of postoperative patients with pancreatic cancer.
Methods: Medical records of patients who underwent pancreatic resection for pancreatic cancer in the department of general surgery, Qilu Hospital, Shandong University were reviewed retrospectively. Demographic, clinicopathological, tumor-specific data, and histopathological reports were collected. Univariate and multivariate survival analyses were performed.
Results: A total of 83 patients with pancreatic cancer were collected. The mean number of examined LN was 8.2 ± 6.1 (0 to 26). Differential degree (low) (P = 0.019, hazard ratio (HR) = 2.276, 95% confidence interval (CI): 1.171 to 4.424) and LNR >0.2 (P = 0.018, HR = 2.685, 95% CI: 1.253 to 5.756) were independent adverse prognostic factors according to the multivariate survival analysis.
Conclusions: Our study indicated that LNR >0.2 was an independent adverse prognostic factor for pancreatic cancer, which may provide important information for prognostic assessment.
Figures
Similar articles
-
Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.Ann Surg Oncol. 2014 May;21(5):1545-51. doi: 10.1245/s10434-013-3473-9. Epub 2014 Jan 14. Ann Surg Oncol. 2014. PMID: 24419758
-
Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.Ann Surg Oncol. 2008 Jan;15(1):165-74. doi: 10.1245/s10434-007-9587-1. Epub 2007 Sep 26. Ann Surg Oncol. 2008. PMID: 17896141
-
Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.J Surg Oncol. 2015 Sep;112(4):396-402. doi: 10.1002/jso.24011. Epub 2015 Aug 25. J Surg Oncol. 2015. PMID: 26303811 Clinical Trial.
-
Surgical resection strategies for locally advanced pancreatic cancer.Langenbecks Arch Surg. 2015 Oct;400(7):757-65. doi: 10.1007/s00423-015-1318-7. Epub 2015 Jun 27. Langenbecks Arch Surg. 2015. PMID: 26115737 Review.
-
Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis and Experience of a Single Center.Med Sci Monit. 2019 Jun 21;25:4590-4601. doi: 10.12659/MSM.914540. Med Sci Monit. 2019. PMID: 31221951 Free PMC article.
Cited by
-
Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas.Front Oncol. 2022 Aug 12;12:927107. doi: 10.3389/fonc.2022.927107. eCollection 2022. Front Oncol. 2022. PMID: 36033500 Free PMC article.
-
Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma.PLoS One. 2020 Jul 14;15(7):e0235904. doi: 10.1371/journal.pone.0235904. eCollection 2020. PLoS One. 2020. PMID: 32663208 Free PMC article.
-
Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study.Front Surg. 2021 Dec 9;8:804785. doi: 10.3389/fsurg.2021.804785. eCollection 2021. Front Surg. 2021. PMID: 34957210 Free PMC article.
-
Comparison of overall survival and perioperative outcomes of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.BMC Cancer. 2019 Aug 7;19(1):781. doi: 10.1186/s12885-019-6001-x. BMC Cancer. 2019. PMID: 31391085 Free PMC article.
-
Prediction scores of postoperative liver metastasis and long-term survival of pancreatic head cancer based on the distance between the mesenteric vessels and tumor, preoperative serum carbohydrate antigen 19-9 level, and lymph node metastasis rate.Cancer Med. 2023 Jan;12(2):1064-1078. doi: 10.1002/cam4.4957. Epub 2022 Jul 13. Cancer Med. 2023. PMID: 35822597 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical